1. -=6
HEADLINES
 Indian Market
 Indian equity markets were down 0.76%
 Nifty down by 44.85 pts and settle at
5871.45
 Sensex up by 120.13 pts at 19286.72
 Bank Nifty up by 193.70 pts at 12533.15
 Global Market
 European markets were up with FTSE
up by 34.88 closed at 6407 ,CAC down
by 37.09 closed at 3803 and DAX down
29.07 closed at 7803
Dow future was down by 33 closed at
14620.00
WWW.EPICRESEARCH.CO 09752199966
DAILY EQUITY
NEWSLETTER
29TH
APRIL 2013
 HEADLINES
• Biocon Q4 net jumps on exceptional
gains; EBITDA down 21%
• FY13 indirect tax exceeds revised
estimate target
• RBS sells 4.62% stake in SKS
Microfinance for Rs 63 cr
• Hero MotoCorp Q4 net profit down 5% to
Rs 574.3 cr

2.  FII’s and DII’s
CATEGORY DATE BUY SELL NET
FII 25-Apr-13 6226.62 4776.92 1449.7
DII 25-Apr-13 1054.58 2324.01 -1269.43
 NIFTY DAILY PIVOTS
PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 6020 5973 5926 5898 5879 5851 5832 5785 5738
WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS:
 Key benchmark indices snapped four day winning streak as weakness in European stocks hit investor
sentiment adversely. The barometer index, the S&P BSE Sensex, was provisionally down 123.50
points or 0.64%, up close to 35 points from the day's low and off about 100 points from the day's high.
The market breadth, indicating the overall health of the market, was negative. Index heavyweight
Reliance Industries (RIL) dropped. Index heavyweight and cigarette major ITC was marginally lower.
 ICICI Bank dropped on profit taking after the bank reported good Q4 results. Idea Cellular surged to hit
52-week high after strong Q4 results. Maruti Suzuki India jumped after the car major reported strong
Q4 March results. LIC Housing Finance jumped on strong Q4 results
 The market edged lower in early trade. The Sensex hovered in negative terrain in morning trade. The
market trimmed losses after hitting fresh intraday low in mid-morning trade. The Sensex continued to
hover in negative terrain in early afternoon trade. Key benchmark indices hovered in red in afternoon
trade. The Sensex weakened once again after paring intraday losses in mid-afternoon trade. The market
trimmed losses after hitting fresh intraday low in late trade.
 S&P BSE Sensex was down 123.50 points or 0.64% to 19,283.35.
 The CNX Nifty was down 43.90 points or 0.74% to 5,872.40.
 Among the 30-share Sensex pack, 19 stocks declined while rest of them rose.
STOCKS TO WATCH
 TCS
 INFOSYS
 MARUTI
 LIC
SCRIPS IN BAN PERIOD

3. WWW.EPICRESEARCH.CO 09752199966
.
EXPERT OPINION
NIFTY
 Nifty looks Bearish
 Strategy: Sell on rise
 Support: 5820
 Resistance: 5910
BANK NIFTY
 Bank Nifty looks Bearish
 Strategy: Sell on rise
 Support: 12480
 Resistance: 12600
460
 .0
 GAINERS AND LOOSERS
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
CASH IDFC B
NOT
EXECUTED
CASH
AURO
PHARMA
B TGT HIT
FUTURE WIPRO S TGT HIT
FUTURE HEXAWARE S SL TRIGERRED
DAILY NIFTY GAINERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHANG
E
Maruti
Suzuki
1673.15 3505.61 1590.95 82.20 5.17
Bharti
Airtel
318.45 7094.56 303.85 14.60 4.81
Bajaj
Auto
1895.70 333.11 1838.00 57.70 3.14
GAIL
India
351.05 1707.16 344.40 6.65 1.93
L & T 1540.85 1247.08 1519.25 21.60 1.42
DAILY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR.
CLOSE
NET
CHAN
GE
%
CHAN
GE
HCL Tech. 684.25 3664.82 719.05 -34.80 -4.84
Jindal
Steel
314.95 6405.62 329.20 -14.25 -4.33
Reliance
Industries
792.40 4766.43 819.65 -27.25 -3.32
JP
Associate
75.00 19781.28 77.45 -2.45 -3.16
Hindustan
Unilever
465.05 2239.63 478.65 -13.60 -2.84

4. 6
.
MARKET CALLS
CASH
SCRIPS ACTION LEVEL 1ST
TARGET 2ND
TARGET STOP LOSS
MPHASIS BUY 377.00 379.00 381.00 375.00
TATA MOTORS BUY 297.00 299.00 301.00 295.00
FUTURE
SCRIPS ACTION LEVEL 1
ST
TARGET 2
ND
TARGET STOP LOSS
TATA STEEL SELL 305.50 303.50 301.50 307.50
WIPRO SELL 330.00 328.00 326.00 324.00
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on
sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of
the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to
buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls
or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious
Legal Actions can be taken.